Navigation Links
The Trendlines Group Announces Co-development Agreement with Endo
Date:11/13/2012

TEL AVIV, Israel, November 13, 2012 /PRNewswire/ --

The Trendlines Group today announced it has entered into an R&D agreement aimed at co-developing novel medical devices and technologies within the areas of pain and urology, a strategic focus  of U.S.-based Endo Health Solutions Inc. (Nasdaq: ENDP).  

The work will be conducted by Trendlines Labs, the technology development arm of The Trendlines Group.  Trendlines Labs is co-located with the Misgav Venture Accelerator - The Trendlines Group's incubator focused exclusively on the development of medtech innovations.  Misgav was named "Best Incubator" by Israel's Office of the Chief Scientist of the Ministry of Industry, Trade and Labor in 2010. Trendlines portfolio company Stimatix (http://www.stimatix-gi.com) was named Israel's best start-up in 2012.

D. Todd Dollinger, Chairman and CEO of Trendlines, stated, "Our work with Endo furthers our market reach and is instrumental to our achieving our mission of creating and developing businesses to improve the human condition."  

Dr. Sujat Sukthankar, Vice President, Device R&D, at Endo said, "The Trendlines-Endo agreement is in line with our stated vision of sourcing innovation globally.  This partnership complements and bolsters our own internal innovation and product development efforts in the areas of pain and urology.  Through this partnership, we are excited to participate in the vibrant medical technology community in Israel. "  

Endo Health Solutions Inc. (http://www.endo.com) is a U.S.-based diversified healthcare company that is redefining healthcare value by finding solutions for the unmet needs of patients along care pathways for pain management, pelvic health, urology, endocrinology and oncology. Through its operating companies: Endo Pharmaceuticals, Qualitest, AMS and HealthTronics, Endo is dedicated to improving care through a combination of branded products, generics, devices, technology and services that creates maximum value for patients, providers and payers alike.

About The Trendlines Group

The Trendlines Group (http://www.trendlines.com) creates and develops businesses to improve the human condition.  Principally through its two Israeli government-licensed business accelerators, Trendlines invests in innovation-based businesses in the areas of medtech and agritech, nurturing high-promise companies while mitigating seed-stage investment risk. The Trendlines group owns the Misgav Venture Accelerator (http://www.misgav-venture.com) which invests in and incubates promising medical device companies and Trendlines Labs, which acts as Trendlines' in-house invention factory, inventing solutions to unmet market needs.

Media relations:
Efrat Sherer-Kaduri
Ofir Shpigel Media and Public Relations
+972-4-9535030


'/>"/>
SOURCE The Trendlines Group
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. China Cord Blood Corporation Announces Completion of Strategic Partnership with Cordlife Group Limited
2. Apexigen Announces Initiation of Clinical Trials By Its Partner, Simcere Pharmaceutical Group
3. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
4. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
5. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
6. VWR International, LLC Acquires Sovereign Group
7. Sosei Group Corporation QVA149 Phase III Study Meets Primary Endpoint in Reducing Exacerbations in COPD Patients and Filings in EU and Japan by End of Year
8. China Cord Blood Corporation and Cordlife Group Limited Foster Closer Alliance Across Asia
9. Astrix Technology Group Awarded Department of Homeland Security BioWatch Laboratory Staffing Contract
10. EAS Consulting Group Realigns Its Management for Growth
11. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Los Angeles, CA (PRWEB) , ... ... ... Pharmaceuticals, Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) ... all uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed ...
(Date:10/10/2017)... Parks Associates announced today that Tom Kerber , Director ... , October 11 in Scottsdale, Arizona . Kerber will ... safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the introduction of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The ... prestigious awards honoring scientists who have made outstanding contributions to analytical ... during Pittcon 2018, the world’s leading conference and exposition for laboratory science, which ...
(Date:10/9/2017)... ... ... At its national board meeting in North Carolina, ARCS® Foundation ... Physics and Astronomy, has been selected for membership in ARCS Alumni Hall of ... Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of the ...
Breaking Biology Technology:
(Date:3/30/2017)... March 30, 2017 The research team of ... three-dimensional (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae ... realm of speed and accuracy for use in identification, crime investigation, ... cost. ... A research ...
(Date:3/28/2017)... India , March 28, 2017 ... IP, Biometrics), Hardware (Camera, Monitors, Servers, Storage Devices), Software ... Vertical, and Region - Global Forecast to 2022", published ... Billion in 2016 and is projected to reach USD ... between 2017 and 2022. The base year considered for ...
(Date:3/24/2017)... Research and Markets has announced the addition ... Trends - Industry Forecast to 2025" report to their offering. ... The Global Biometric ... of around 15.1% over the next decade to reach approximately $1,580 ... market estimates and forecasts for all the given segments on global ...
Breaking Biology News(10 mins):